Ionis Pharmaceuticals Inc (IONS) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $80.60
• Market Cap: $13.11B
• EPS: $-1.61
• 52-Week High: $86.74
• 52-Week Low: $23.95

Market Sentiment

Ionis Pharmaceuticals Inc currently has a Neutral sentiment score of 0.12.

About Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals, Inc. is a pioneering biopharmaceutical company based in Carlsbad, California, renowned for its innovative RNA-targeted therapies designed to address severe and complex diseases. Utilizing its proprietary antisense technology, Ionis is dedicated to fulfilling unmet medical needs across various therapeutic areas, including neurological disorders, cardiovascular diseases, and oncology. With a diverse pipeline featuring both proprietary assets and strategic collaborations, ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Ionis Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does IONS pay dividends?

Ionis Pharmaceuticals Inc (IONS) does not currently pay a regular dividend.

What is IONS's market cap?

Ionis Pharmaceuticals Inc (IONS) has a market capitalization of $13.11B with a current stock price of $80.60.